1 - Et åbent, randomiseret, non- komparativt multicenter- forsøg med patienter med behandlingssvigt ved initial behandling med 400 eller 600 mg imatinib.
1- An open-label, randomised, non-comparative multicenter study was conducted in patients who failed initial treatment with 400 or 600 mg imatinib.